Are DSGR, OPCH, PRTH, UTZ Obtaining Fair Deals for their Shareholders?
Are DSGR, OPCH, PRTH, UTZ Obtaining Fair Deals for their Shareholders?PR NewswireNEW YORK, Oct. 18, 2026Insiders may stand to receive substantial financial bene
OPCH - Option Care Health, Inc.
Price:
--
--
|
CONSENSUS:
Hold
DETAILS
|
PRICE TARGET:
$28.78
DETAILS
HIGH:
$32.05
LOW:
$22.00
MEDIAN:
$32.02
CONSENSUS:
$28.78
DOWNSIDE:
7.59%
Stock News
Are DSGR, OPCH, PRTH, UTZ Obtaining Fair Deals for their Shareholders?
/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws
Cencora (NYSE:COR) and Option Care Health (NASDAQ:OPCH) Financial Contrast
Cencora (NYSE: COR - Get Free Report) and Option Care Health (NASDAQ: OPCH - Get Free Report) are both healthcare companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, dividends, risk, analyst recommendations, profitability, valuation and earnings. Earnings and Valuation This table compares Cencora and
OPCH Alert: Monsey Firm of Wohl & Fruchter Investigating Fairness of the Proposed Sale of Option Care Health to CD&R and McKesson
MONSEY, N.Y., Oct. 13, 2026 (GLOBE NEWSWIRE) -- The law firm of Wohl & Fruchter LLP is investigating the fairness of the proposed sale of Option Care Health, Inc. (NASDAQ: OPCH) (“OPCH”) to CD&R and McKesson Corporation for $32.05 per share in cash.
Are OPCH, PCRX, RXO, BOLD Obtaining Fair Deals for their Shareholders?
Are OPCH, PCRX, RXO, BOLD Obtaining Fair Deals for their Shareholders?PR NewswireNEW YORK, Oct. 12, 2026Insiders may stand to receive substantial financial bene
Are OPCH, PCRX, RXO, BOLD Obtaining Fair Deals for their Shareholders?
/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws
OPCH Investors Have Opportunity to Join Option Care Health, Inc. Fraud Investigation with SBS Law
LOS ANGELES--(BUSINESS WIRE)---- $OPCH--OPCH Investors Have Opportunity to Join Option Care Health, Inc. Fraud Investigation with SBS Law.
SHAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Option Care Health, Inc. (NASDAQ: OPCH)
SHAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Option Care Health, Inc. (NASDAQ: OPCH)PR NewswireNEW YORK, Oct. 11, 2026NEW YORK, Oc
SHAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Option Care Health, Inc. (NASDAQ: OPCH)
NEW YORK, Oct. 11, 2026 /PRNewswire/ -- Class Action Attorney Juan Monteverde with Monteverde & Associates PC (the "M&A Class Action Firm"), has recovered millions of dollars for shareholders and is recognized as a Top 50 Firm in the 2025 ISS Securities Class Action Services Report. The firm is headquartered at the Empire State Building in New York City and is investigating Option Care Health, Inc. (NASDAQ: OPCH ) related to its sale to an investor group comprised of affiliates of Clayton, Dubilier & Rice, LLC and McKesson Corporation.
Option Care Health Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Option Care Health, Inc. - OPCH
NEW YORK CITY & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Option Care Health, Inc. (NasdaqGS: OPCH) to CD&R, McKesson Corporation. Under the terms of the proposed transaction, shareholders of Option Care will receive $32.05 in cash for each share of Option Care that they own. KSF is seeking to determine whether this consideration and the process t.
This Option Care Health Analyst Is No Longer Bullish; Here Are Top 4 Downgrades For Wednesday
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.
Strength Seen in Option Care (OPCH): Can Its 32.7% Jump Turn into More Strength?
Option Care (OPCH) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
Halper Sadeh LLC is Investigating Whether PTC and OPCH are Obtaining Fair Deals for their Shareholders
Insiders may stand to receive substantial financial benefits not available to ordinary shareholders.
OPCH SHAREHOLDER ALERT: ADEMI LLP INVESTIGATES WHETHER BUYOUT FAIRLY VALUES OPTION CARE HEALTH, INC.
OPCH SHAREHOLDER ALERT: ADEMI LLP INVESTIGATES WHETHER BUYOUT FAIRLY VALUES OPTION CARE HEALTH, INC.PR NewswireMILWAUKEE, Oct. 6, 2026Option Care Health shareho
OPCH SHAREHOLDER ALERT: ADEMI LLP INVESTIGATES WHETHER BUYOUT FAIRLY VALUES OPTION CARE HEALTH, INC.
Option Care Health shareholders will receive just $32.05 per share, representing a total enterprise value of approximately $5.8 billion; Ademi LLP is investigating the deal price, benefits to company insiders, and restrictions on competing offers CLICK HERE TO JOIN MILWAUKEE, Oct. 6, 2026 /PRNewswire/ -- Ademi LLP is investigating whether the proposed acquisition of Option Care Health (NASDAQ: OPCH) by CD&R and McKesson Corporation, provides fair value to Option Care Health's public shareholders and whether Option Care Health's Board adequately protected shareholder interests in negotiating and approving the transaction. Are You a Option Care Health Shareholder?
Option Care Stock Trades Below McKesson's Deal Price — Here's the Spread
Option Care Health Inc. (NASDAQ:OPCH) agreed Tuesday to be taken private by Clayton Dubilier & Rice and McKesson Corp. (NYSE:MCK) for $32.05 a share in cash. The deal gives the home-infusion provider a total enterprise value of about $5.8 billion.
Why Option Care Health Stock Skyrocketed on Tuesday
Option Care is being bought out by McKesson and private equity firm Clayton Dubilier & Rice. The deal values Option Care at $32.05 per share or about $5.8 billion.
OPCH Stock Alert: Halper Sadeh LLC is Investigating Whether Option Care Health, Inc. is Obtaining a Fair Price for its Shareholders
Halper Sadeh LLC, an investor rights law firm, is investigating the sale of Option Care Health, Inc. (NASDAQ: OPCH) to CD&R, McKesson Corporation for $32.05 per
OPCH Stock Alert: Halper Sadeh LLC is Investigating Whether Option Care Health, Inc. is Obtaining a Fair Price for its Shareholders
NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating the sale of Option Care Health, Inc. (NASDAQ: OPCH) to CD&R, McKesson Corporation for $32.05 per share. Halper Sadeh encourages Option Care shareholders to click here to learn more about their rights and options or contact Daniel Sadeh or Zachary Halper free of charge at (212) 763-0060 or [email protected] or [email protected]. The investigation concerns whether Option Care and its board of.
Is Option Care Health (OPCH) Stock Undervalued Right Now?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Price Targets
Option Care Health downgraded to Equal Weight from Overweight at Morgan Stanley
$32.05
(was $31.07)
Morgan Stanley
Option Care Health downgraded to Neutral from Buy at UBS
$32.05
(was $31.07)
UBS
Option Care Health downgraded to Hold from Buy at Truist
$32.05
(was $31.00)
Truist Financial
Option Care Health downgraded to Hold from Buy at Jefferies
$32.05
(was $31.00)
Jefferies
Deutsche Bank Downgrades Option Care Health (OPCH) to Hold
$24.00
(was $23.93)
Pito Chickering
·
Deutsche Bank
Option Care Health downgraded to Equal Weight from Overweight at Stephens
$24.00
(was $22.10)
Raj Kumar
·
Stephens
Goldman Sachs Starts Option Care Health (OPCH) at Neutral
$22.00
(was $20.51)
Scott Fidel
·
Goldman Sachs
Option Care Health price target lowered to $28 from $38 at Morgan Stanley
$28.00
(was $21.47)
Morgan Stanley
Option Care Health price target lowered to $30 from $40 at Truist
$30.00
(was $20.02)
Truist Financial
Option Care Health price target lowered to $32 from $42 at Barrington
$32.00
(was $20.02)
Barrington
Option Care Health price target lowered to $39 from $45 at UBS
$39.00
(was $20.05)
UBS
Option Care Health price target lowered to $30 from $40 at Stephens
$30.00
(was $20.15)
Stephens
Option Care Health price target lowered to $26 from $38 at Deutsche Bank
$26.00
(was $20.33)
Pito Chickering
·
Deutsche Bank
Option Care Health (OPCH) PT Raised to $37 at TD Cowen
$37.00
(was $35.22)
National Bank
Option Care Health price target raised to $42 from $38 at Barrington
$42.00
(was $36.11)
Michael Petusky
·
Barrington
Option Care Health (OPCH) PT Raised to $37 at Jefferies
$37.00
(was $34.52)
Brian Tanquilut
·
Jefferies
Truist Securities Reiterates Buy Rating on Option Care Health (OPCH)
$40.00
(was $34.67)
David MacDonald
·
Truist Financial
Option Care Health initiated with an Overweight at Stephens
$40.00
(was $33.09)
Stephens
Option Care Health price target lowered to $36 from $38 at Citizens JMP
$36.00
(was $26.20)
Constantine Davides
·
JMP Securities
Option Care Health initiated with an Overweight at Morgan Stanley
$35.00
(was $27.10)
Morgan Stanley